Psychotropic drugs affect your mood, behavior and perception by changing the way your brain functions. The drugs mainly target the central nervous system by leaving the blood and entering the brain. They are prescribed for various symptoms and diseases that include but are not limited to anxiety, depression, bipolar disorder, attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD) and schizophrenia.
Specifically, the antidepressants known as selective serotonin reuptake inhibitors (SSRIs) are used to correct low levels of serotonin in the brain, which has been suggested to be a “chemical imbalance.” Many patients believe they have this “chemical imbalance” that requires medication, such as Zoloft. However, science has failed to prove this serotonin theory do to lack of conclusive evidence1. In 2005, the president of the American Psychological Association, Stephen Sharfstein, said that there is no evidence to prove that chemical imbalances are related to mental disorders2.
In addition, psychotropic drugs have been shown to cause serious side effects, such as diabetes, heart disease, miscarriages, weight gain and suicidal thoughts in children and adolescents, to name a few. As of 2008, a total of 63,000 people had committed suicide while taking SSRIs2. Interestingly enough, these SSRIs were known back in the 1980s to cause violent behaviors and suicidal thoughts before they even went on the market to be sold!
The primary side effect that you should be concerned about is that antidepressants can actually increase your risk of suicide, and your risk for type 2 diabetes is two to three times higher if you take antidepressants. Antidepressants, including tricyclic and SSRIs, increase type 2 diabetes risk.
Side note about diet and depression: a recent University of London study, led by Dr. Eric Brunner, followed the eating habits of 3,486 adults for 5 years. The study revealed that those who ate diets high in processed and fast foods were almost 60% more likely to suffer from depression.
New onset diabetes has been found in individuals taking psychotropic drugs with no previous medical history of diabetes. Individuals were diagnosed on average three to six months after starting psychotropic medication. The likelihood of developing diabetes is up to ten times higher in individuals taking psychotropic drugs compared to individuals not on the medications3.
Researchers found a link between psychotropic drug usage and sudden cardiac death. This could be in part due to the dosage, the toxins in the drugs and/or underlying cardiac risk. When taking psychotropic drugs, sudden cardiac death is more likely to occur in the individuals as risk for cardiac disease when compared to their healthy counterparts4. Additionally, psychotropic drugs have been shown to cause less drastic cardiac problems, such as irregular heartbeat and high blood pressure that occur in patients with no cardiac risk prior to consumption of the drug5.
Researchers have suggested that pregnant women with anxiety or depression are more likely to have a miscarriage or perinatal death when taking psychotropic drugs during their first trimester when compared to women who did not take the drugs6. Another study found similar results with pregnant women twice as likely to have a miscarriage or spontaneous abortion and three times as likely for the baby to have abnormalities if prescribed a psychotropic drug during the first trimester7. There have also been reports that pregnant women exposed to the SSRI Paxil were twice as likely to have babies with major birth defects, primarily heart malformations8-9.
If overweight or obese, weight gain can lead to fatal disorders, such as diabetes and heart disease. One study compared over 660 clinical trials and determined that weight gain was associated with psychotropic drug use10. Unfortunately, the amount of weight gain could not be determined due to the vast number of studies compared. However, it was concluded that weight gain was more likely in individuals with previous psychotropic drug exposure.
CHILDREN AND ADOLESCENTS
The number of psychotropic drugs prescribed to adolescents between the ages of 14 and 18 increased 250% from 1994 to 200111. A randomized control trial looking at 1,000 individuals found that children taking a SSRI or children that recently stopped taking a SSRI were almost three times more likely to commit suicide (3.4%) than those taking the placebo (1.2%)12. Similar results showed that children prescribed antidepressants were twice as likely to commit suicide than children not prescribed psychotropic drugs13.
In regards to depression, a number of studies found that SSRIs did not improve depressive symptoms in children when compared to the placebo group14-15. The sad truth is that not only do psychotropic drugs potentially increase suicide in children, but there is little evidence to suggest that they even help the symptoms.
There are usually many underlying causes to mental challenges or dysfunctions, emotionally and physically, and can stem from lifestyle. Some causes can be a lack of Vitamin D, Vitamin B12, too much salt or sugar in your diet, not eating enough healthy fats like Omega-3’s, lack of sleep, and lack of exercise.
Remember, drugs should be your last choice. If you or your child is suffering from an emotional or mental challenge, please do seek help, but I recommend finding a professional who does not prescribe psychotropic drugs as a first, or only, form of defense.
If you or your children are taking psychotropic drugs, I strongly urge you to educate yourself and work with your physician to seek alternative options. Instead of dangerous medications, first seek counseling and truly address the root cause of any depression or behavioral disorder. Also address other dietary and lifestyle issues like Omega-3 and niacin deficiencies, mercury toxicity and lack of exercise.
1. Lacasse, J. R., and J. Leo. “Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature.” PLoS medicine 2.12 (2005): e392. Print.
2. CCHR: Exposing the Dangers of Antidepressants and Other Psychotropic Drugs—Despite FDA/Psychiatric-Pharmaceutical Cover-Ups. CCHR Report. 2008.
3. Sharav, V. H. “Children in Clinical Research: A Conflict of Moral Values.” The American journal of bioethics : AJOB 3.1 (2003): W,IF 2. Print.
4. Timour, Q., et al. “Sudden Death of Cardiac Origin and Psychotropic Drugs.” Frontiers in pharmacology 3 (2012): 76. Print.
5. Marano, G., et al. “Cardiologic Side Effects of Psychotropic Drugs.” Journal of geriatric cardiology : JGC 8.4 (2011): 243-53. Print.
6. Ban, L., et al. “Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study.” PloS one 7.8 (2012): e43462. Print.
7. Prozac: Child Abuse, CCHR Report, 1994.
8. Benedict Carey, “Paxil Alert for Pregnant Women,” The New York Times, 29 September, 2005; Miranda Hitti,
9. “New Study Links Paxil to Twice as Many Birth Defects as Other Antidepressants,” WebMD Medical News, 27 Sept. 2005.
10. Dent, R., et al. “Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature.” PloS one 7.6 (2012): e36889. Print.
11. “DTC Ads Linked to Rise in Drug ‘Scripts for Teens,” Psychiatric Times, Apr. 2006, Vol. XXIII, No. 4.
12. Dave Altimari, Memos Display Drug Firms’ Optimism Officials Were Confident FDA Would Back Them On Suicide, Violence Issues Involving Paxil, Prozac,” Hartford Courant, 21 Sept. 2003.
13. Anna Wilde Mathews, “FDA Will Seek to Revise Antidepressant Labels for Youth,” The Wall Street Journal, 20 Aug. 2004; Gardiner Harris, “Antidepressant Study Seen to Back Expert,” The New York Times, 20 Aug. 2004.
14. Gardiner Harris, “Antidepressant Study Seen to Back Expert,” The New York Times, 20 Aug. 2004.
15. Joe Barton, Chairman, U.S. House of Representatives, Committee on Energy and Commerce, website, 24 Mar. 2004